Rick Mignella, executive vice president and managing director will lead the U.S. team and focus on scaling up business to expand the company’s presence within the North American market.
Photo © Shutterstock.com/Madlen
Equinom Ltd. (Kibbutz Givat Brenner, Israel), is expanding operations to the North American market by opening offices in the U.S. Equinom’s business model directly connects food companies to the supply chain, increasing transparency and leading to responsible sourcing of high value plant protein.
Rick Mignella, executive vice president and managing director will lead the U.S. team and focus on scaling up business to expand the company’s presence within the North American market. Prior to Equinom, Mignella held strategic business development positions for Ingredion and Cargill.
“Equinom can significantly contribute to the plant-based revolution and the broader food industries by changing the way food systems currently operate,” stated Mignella in a press release. “Equinom’s non-GMO technology can help facilitate the creation of clean food products, increase protein content, and tailor key nutrients to the specific requests of food product developers and manufacturers. Our mission of connecting the farming industry with the food companies will build the next-generation mutual ecosystem for food production.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.